Product Details
Place of Origin: China
Brand Name: Sunshine
Certification: ISO,COA
Model Number: 159351-69-6
Payment & Shipping Terms
Minimum Order Quantity: Negotiation
Price: Negotiation
Packaging Details: Aluminum Foil Bag, Drum
Delivery Time: 7-15 days
Payment Terms: T/T, L/C, D/A, Western Union
Supply Ability: TON
CAS NO:: |
159351-69-6 |
Appearance:: |
Off-white To Light Yellow Powder |
Molecular Formula:: |
C53H83NO14 |
Molecular Weight:: |
958.224 |
EINECS NO:: |
621-003-9 |
MDL NO:: |
MDL NO: MFCD07785165 |
CAS NO:: |
159351-69-6 |
Appearance:: |
Off-white To Light Yellow Powder |
Molecular Formula:: |
C53H83NO14 |
Molecular Weight:: |
958.224 |
EINECS NO:: |
621-003-9 |
MDL NO:: |
MDL NO: MFCD07785165 |
Product Description:
Product Name: Everolimus CAS NO:159351-69-6
Synonyms:
42-O-(2-Hydroxyethyl)-rapamycin;
Chemical & Physical Properties:
Appearance: off-white to light yellow powder
Assay :≥99.0%
Density:1.18 g/cm3
Boiling Point:998.7℃ at 760 mmHg
Flash Point:557.8℃
Everolimus is the 40-O-(2-hydroxyethyl) derivative of sirolimus and works similarly to sirolimus as an inhibitor of mammalian target of rapamycin (mTOR).
It is currently used as an immunosuppressant to prevent rejection of organ transplants and treatment of renal cell cancer and other tumours. Much research has also been conducted on everolimus and other mTOR inhibitors as targeted therapy for use in a number of cancers.
It is marketed by Novartis under the tradenames Zortress (USA) and Certican (Europe and other countries) in transplantation medicine, and as Afinitor (general tumours) and Votubia (tumours as a result of TSC) in oncology. Everolimus is also available from Biocon, with the brand name Evertor.
If you are interested in our products or have any questions, please feel free to contact us!
Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.
